CD4 and neuroblastoma: We previously showed that immunotherapy with the immune-enhancing cytokine IL-2119 in combination with an anti-CD4 mAb was highly effective in a syngeneic model of disseminated NB, through the activation of a cytotoxic T-lymphocyte (CTL) response20,21.